A study at The University of Texas MD Anderson Cancer Center revealed the investigational drug umbralisib as an effective treatment for patients with relapsed marginal zone lymphoma (MZL). Findings from the Phase II trial ...
Apr 1, 2019
0
0
People with a certain type of lymphoma will now have access to a targeted cancer drug on the NHS in England.
Mar 22, 2019
0
3
A research team led by the Yale School of Public Health has found that for people living with HIV/AIDS, both recent immunosuppression (a low recent CD4 T-cell count [white blood cells that fight infection]) and prolonged ...
Mar 21, 2019
0
6
Patients living with an aggressive form of lymphoma in Scotland will not get routine access to a new immunotherapy treatment after it was rejected for use on the NHS.
Mar 14, 2019
0
3
The use of textured breast implants during augmentation or reconstructive surgery can slightly increase a patient's risk of developing Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), a form of cancer ...
Mar 12, 2019
0
3
A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis. It can be important to adapt early on as to what treatment to ...
Mar 7, 2019
0
1
For just the second time ever an HIV patient is in sustained remission from the virus in what was hailed by experts Tuesday as proof that the AIDS-causing condition could one day be curable.
Mar 5, 2019
0
562
Healthy white blood cells, called "T-cells," play a crucial role in how the body fights follicular lymphoma. That's according to the results of a study led by Mayo Clinic hematologists Zhi Zhang Yang, M.D., and Stephen Ansell, ...
Feb 20, 2019
0
60
Many patients with lymphoma take longer to be diagnosed than expected, with some thinking these delays could have been avoided, a new report from the University of York has found.
Jan 29, 2019
0
0
People with a certain type of lymphoma will not be able to receive a targeted cancer drug on the NHS in England.
Dec 21, 2018
0
3
